NVDA vs QUIK

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

With a Piotroski F-Score of 1/9, QUIK exhibits severe financial distress and deteriorating fundamental health. The company is currently facing a critical combination of shrinking revenues (-34.20% YoY) and deep operational losses, evidenced by a profit margin of -107.56%. Despite a recent speculative surge in share price, the valuation is fundamentally disconnected from performance, trading at a high Price/Sales ratio of 15.36 and well above the analyst target price of $9.67. Insider selling and a consistent track record of missing earnings estimates further reinforce a high-risk profile.